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ABSTRACT
Objective: To investigate the existence of vitamin D deficiency (VDD) among Type 2 diabetes, nondiabetes individuals and its effect on both glycemic 
and lipid profiles.
Methods: A case-control study was conducted on 200 subjects of both genders (100 Type 2 diabetes and 100 nondiabetes individuals) aged 
40-60 years. Fasting serum 25-hydroxycholecalciferol (25(OH) D) levels, fasting blood sugar (FBS), hemoglobin A1c (HbA1c), lipid profile including 
total cholesterol (TC), triglycerides (TGs), high density lipoprotein (HDL), low density lipoprotein (LDL), TC/HDL, and very LDL were estimated. 
Atherogenic index of plasma (AIP) was calculated. Group comparisons were done by one-way analysis of variance followed by post-hoc Tukey’s test 
and Student’s independent t-test. Chi-square test was performed for categorical variables. Correlation was done by Pearson’s analysis. p<0.05 was 
considered significant.
Results: The average serum 25(OH) D levels were significantly (p<0.001) low in diabetes group. The prevalence of VDD and the percentage of 
insufficient and sufficient categories was significantly (p<0.001) high and low, respectively, in diabetes group. In the deficient category, diabetes group 
had severe VDD with significantly low-HDL and elevated TGs and there was an insignificant but negative association between serum vitamin D levels, 
FBS, HbA1c, TC, TG, LDL, TC/HDL, and AIP among diabetes patients.
Conclusion: The occurrence of severe VDD coupled with the independent association of the same with the glycemic and lipid profiles in Type 2 
diabetes may further add to the aggravation of complications
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INTRODUCTION
Vitamin D deficiency (VDD) is a globally widespread pandemic [1] that 
affects the functions of various physiological systems. Over the past 
decade, the extraskeletal effects of vitamin D are gaining importance. 
The discovery of vitamin D receptors (VDRs) in various organs 
coupled with the local synthesis of vitamin D strengthen this concept 
further [2]. VDD could well be a new risk factor for many diseases such 
as hypertension [3], cardiovascular disease [4,5], Type 1 and Type 2 
diabetes [6], immune disorders, osteoporosis, and cancer [7].
Over 50% Type 2 diabetes mellitus (T2DM) patients have <20 ng/L of 
serum 25 hydroxy vitamin D (25(OH) D) level [8]. The American Diabetic 
Association and the American Heart Association strongly recommended 
the control of nonglycemic risk factors in diabetes patients to halt 
the onset as well as propensity of various complications [1]. Studies 
regarding the influence of serum vitamin D levels on diabetes and its 
associated dyslipidemia yielded conflicting results [9-11] and there are 
few comparative studies on the prevalence of VDD among individuals 
with and without diabetes [12]. In an attempt to address the same, 
this study is aimed to investigate the existence of VDD among diabetes 
patients as compared to nondiabetes individuals and its effect on both 
glycemic status and lipid profile.
METHODS
This is a hospital-based case-control study conducted on 200 subjects 
of both genders (100 diabetes and 100 nondiabetes individuals) aged 
40-60 years. The study protocol was approved by Institutional Ethics 
Committee (No. IEC KMC MLR 02-14/27) and the participants were 
enrolled after obtaining duly signed informed consent. Individuals who 
were on vitamin D supplementation and subjects with any acute or 
chronic illness as documented by history were excluded from the study. 
Fasting serum 25(OH) D levels (Diasource, USA) by enzyme-linked 
immunosorbent assay, fasting blood sugar (FBS), lipid profile including 
total cholesterol (TC), triglycerides (TG), high density lipoprotein 
(HDL), low density lipoprotein (LDL), TC/HDL, and very LDL (VLDL) 
were estimated using COBAS – 600 autoanalyzer. Hemoglobin A1c 
(HbA1c) estimation was done in D-10 BioRad analyzer. Atherogenic 
index of plasma (AIP) was calculated with Dobiasova M. calculator [Log 
(TG/HDL-C)]. Based on the serum 25(OH) D levels the study population 
was divided into three groups as per Institute of Medicine guidelines. 
Deficient <20 ng/mL, insufficient 21-29 ng/mL, and sufficient 
>30 ng/mL.
Statistical analysis
The data were analyzed in SPSS V 17.0. The results were expressed 
as mean±standard deviation, median and interquartiles. Comparison 
between the groups was done by analysis of variance followed by 
Tukey’s multiple comparison test and Student’s independent t-test. 
Categorical variables were analyzed by Chi-square test. The correlation 
was done by Pearson’s analysis. p<0.05 was considered significant.
RESULTS
Among diabetes and nondiabetic groups the mean age and male:female 
ratio was found to be 49.76±5.21 years versus 48.52±6.03 years and 
63:37 versus 66:34, respectively. The average serum 25(OH) D levels 
were significantly (p<0.001) low in diabetes group (9 [5, 14] vs. 
19 [12, 28]) ng/mL (Tables 1 and 2). Compared to nondiabetes group 
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the prevalence of VDD was significantly high in diabetes group (54% 
vs. 86%) and the percentage of insufficient and sufficient categories 
were also significantly low (5% and 9% vs. 25%, and 21%) respectively 
in diabetes group (Fig. 1). In the VDD category (n=140), the ratio of 
diabetes versus nondiabetic individuals was found to be 86:54 and the 
diabetes group had severe VDD with significantly low-HDL, elevated 
TGs, TC/HDL ratio, and AIP (Table 3). Although insignificant there was 
a negative association between serum vitamin D levels FBS, HbA1c, TC, 
TG, LDL, TC/HDL, and AIP among diabetes patients (Table 4).
DISCUSSION
VDD is considered as a global pandemic and has been reported in healthy 
population. More than 90% of relatively healthy Indians have low 25(OH) 
D levels. The common causes for VDD in apparently healthy individuals 
are low dietary intake and indoor life style with minimal exposure to 
sunlight [13]. It has been proposed that low serum vitamin D levels 
predispose individuals to T2DM [14]. Studies also demonstrated higher 
prevalence of VDD among diabetes patients compared to nondiabetic 
individuals [14]. In this study, more than half (54%) of the nondiabetic 
individuals were found to have VDD whereas the extent of VDD was 
much higher (86%) in diabetic group (Fig. 1). These findings reiterate 
the previous reports of widespread VDD even among apparently healthy 
subjects and those affected by diabetes are more severely affected. 
Diabetes patients are more prone to VDD has been supported by previous 
studies where Boucher B et al., Isaia G et al., Mattila C et al., reported 
correlation of low serum 25(OH) D concentrations with impaired glucose 
tolerance and an increased risk of Type 2 diabetes [14-16]. Evidence 
from cross-sectional studies showed that low serum 25-(OH) D levels are 
linked to impaired glucose tolerance and diabetes [18]. A meta-analysis of 
21 prospective studies concluded that lower serum vitamin D levels are 
associated with hyperglycemia and insulin resistance [19]. The presence 
of VDR and vitamin D binding proteins (VDBP) in pancreatic tissues 
strengthen the concept of vitamin D being essential for insulin synthesis 
and secretion [14]. The probable mechanisms for VDD among diabetes 
patients could be obesity, (vitamin D being fat soluble gets sequestered 
in adipose tissue leading to low serum levels) decreased VDBP secondary 
to reduced function or availability of megalin or low density lipoprotein-
related protein 2 (hasten the metabolism and elimination of active form 
of vitamin D) [20].
Vitamin D was proposed to exert favorable actions in Type 2 DM 
patients through the following pathways, (i) Improved β-cell function 
Table 1: Parameters of diabetes subjects compared among vitamin D categories
Parameters <20 (n=86) 20.1‑29.9 (n=5) >30 (n=9) Total (n=100)
Age 49.37±5.24 52.6±6.06 51.88±3.72 49.76±5.21
Vitamin D 8.51±4.70 22.82±1.48 43.93±10.23 9 (5,14)*
FBS 162.18±51.57 143.4±28.54 160.11±58.25 161.06±51.06
HbA1c 8.36±1.86 7.84±0.70 8.05±1.48 8.31±1.78
TC 186.10±43.81 187.4±64.98 185.55±31.12 186.12±43.55
TG 164.16±86.10 108.8±32.32 149.55±64.09 160.08±83.05
HDL 40.81±9.27 45.86±11.65 47.91±18.20 41.70±10.54
LDL 129.76±38.72 133.98±66.21 124.22±29.30 129.47±39.21
TC/HDL 4.72±1.39 4.24±1.52 4.26±1.38 4.65±1.39
AIP 0.23±0.19 0.05±0.06 0.18±0.21 0.21±0.19
VLDL 32.83±17.2 21.74±6.47 29.91±12.81 32.01±16.61
Male:Female 53:33 3:2 7:2 63:37
Expressed as Mean±SD. Groups were compared by one way Anova followed by Tukey’s multiple comparison test. Categorical variables were analyzed by chi-square 
test. FBS: Fasting blood sugar, TC: Total cholesterol, TG: Triglycerides, HDL: High density lipoprotein, LDL: Low density lipoprotein, AIP: Atherogenic index of plasma, 
VLDL: Very low density lipoprotein, HbA1c: Hemoglobin A1c
Table 2: Study parameters in non‑diabetes group compared among vitamin D categories
Parameters <20 (n=54) 21‑29 (n=25) >30 (n=21) Total (n=100)
Age 48.29±6.35 48.88±5.90 48.66±5.59 48.52±6.03
Vitamin D 11.77±4.92 24.26±3.05 45.57±13.78 19 (12,28)*
FBS 96.77±8.12 98.4±9.03 98.28±9.07 97.5±8.51
HbA1c 5.48±0.42 5.62±0.53 5.67±0.37 5.56±0.44
TC 197.53±37.17 194±31.60 197.23±31.74 196.59±34.47
TG 128.03±60.21 120.84±54.23 120.33±37.43 124.62±54.32
HDL 49.04±12.12 52.01±13.68 48.08±13.62 49.58±12.79
LDL 133.92±33.87 128±30.13 135.24±27.61 132.72±31.56
TC/HDL 4.19±0.98 3.93±1.11 4.45±1.59 4.18±1.16
AIP 0.12±0.16 0.09±0.15 0.10±0.15 0.11±0.16
VLDL 25.01±12.33 23.88±10.84 24.06±7.48 24.53±11.02
Male:Female 37:17 13:12 16:5 66:34
*Expressed as Mean±SD. Groups were compared by one way Anova followed by Tukey’s multiple comparison test. Categorical variables were analyzed by chi-square 
test.. FBS: Fasting blood sugar, TC: Total cholesterol, TG: Triglycerides, HDL: High density lipoprotein, LDL: Low density lipoprotein, AIP: Atherogenic index of plasma, 
VLDL: Very low density lipoprotein, HbA1c: Hemoglobin A1c
Fig. 1: Comparison of vitamin D status between diabetes and 
nondiabetes groups
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via direct effect of vitamin D or by increase in the intracellular Ca2+ 
concentration which in turn boost insulin release, (ii) augmentation 
of insulin sensitivity in target cells through glucose transporter 
type 4 translocation and insulin receptor expression via calcium-
dependent pathways ultimately leading to better glucose utilization 
and (iii) inhibition of β-cells apoptosis via VDR transcription factor 
mediated inhibition of cytotoxic gene expression [21]. In diabetes 
patients of this study, there was a negative but nonsignificant correlation 
of glycemic profile with vitamin D status (Table 4). When compared 
across the vitamin D categories the deficient group had high fasting 
sugar and HbA1c levels than insufficient and sufficient groups but the 
difference was not statistically significant. Paradoxically, the insufficient 
category has better glycemic profile than sufficient group (Table 1). 
Diabetes group had a significant severe form of VDD compared to the 
apparently healthy individuals suggesting that this population are at 
high risk of developing VDD and this is in acceptance with the previous 
studies [21,22]. In a study conducted on 83,779 women for 20 years 
reported the role of vitamin D in attenuating the risk of T2DM [23]. It 
has been shown that restoration of serum vitamin D levels to normal 
lead to the improvement of glucose tolerance [24,25].
Data from previous studies pointed the role of serum 25(OH) D levels 
in dyslipidemia. Nevertheless, the exact mechanism(s) relating VDD 
with dyslipidemia are not well known and there exist disparity [27]. 
In the current study, there was no significant difference in serum lipid 
profile across the vitamin D categories of both the groups  (Tables 1 
and 2) but in the diabetes group the deficient category had elevated 
TGs, AIP, and low-HDL compared to other two categories. Similar to the 
glycemic profile the lipid profile was also better in insufficient category 
which may be related to the specific pharmacotherapy of these patients. 
Jorde R, Grimnes G [28] reported a positive correlation between 
vitamin D status and HDL whereas, Xinyan Bi et al. [11] found no such 
association but they reported a significant inverse relation between 
TC/HDL, LDL/HDL ratios and serum 25(OH) D levels. In this study, 
insignificant but negative and positive associations were reported 
between serum 25(OH) D levels, TC, TGs, TC/HDL ratio, AIP and HDL, 
respectively, among the diabetes patients (Table 4). An AIP above 
0.5 has been a suggestive of atherogenic risk [29]. Although diabetes 
patients of deficient category had higher AIP compared to nondiabetes 
group irrespective of the vitamin D status it is within the specified cut 
off. Saedisomeolia et al. [30] established a statistically insignificant 
positive relation between serum 25(OH) D levels, LDL, and TC. They 
also showed an inverse relationship between serum 25(OH) D and TG 
levels in diabetes individuals. Venkatesh G et al. showed that exposure 
to sun light had no significant changes on lipid profile of prediabetes 
subjects. The authors highlighted the need for appropriate vitamin D 
supplementation with intensive life style changes for the prevention or 
delay of T2DM progression [31].
The modulatory effects of vitamin D on lipid profile has been through 
direct and indirect effects and its role in attenuation of serum TGs may 
be due to the regulatory action that increases the lipoprotein lipase 
activity in adiposity [31]. The role of calcium-mediated regulation of 
cholesterol and other components of lipid profile is not well known. In 
a study conducted by Querfeld et al. [32] they reported that vitamin D 
supplementation had a significant effect over specific components of 
lipid profile and revealed 8% (0.28 mmol/L) increase in serum LDL-C 
and a 16% (0.22 mmol/L) decrease in serum TG compared to the 
placebo group.
The strengths of the study are comparison of serum vitamin D levels 
between diabetes and nondiabetes individuals with reference to the 
severity of VDD among diabetes patients with an emphasis on deficient 
category between the groups. The limitation is the influence of diabetes, 
drug therapy and other comorbidities on the study variables was not 
considered.
CONCLUSION
The occurrence of severe VDD coupled with the negative association 
of the same although insignificant with the glycemic and lipid 
profiles excluding HDL in diabetes population may further add to the 
aggravation of complications in already compromised situation. Hence, 
maintenance of adequate serum vitamin D levels should be a priority 
especially in diabetes individuals.
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